We are live on ! Find out more
OSH

Oak Street Health, Inc.

Delisted

OSH was delisted on the 1st of May, 2023.

219 hedge funds and large institutions have $4.89B invested in Oak Street Health, Inc. in 2022 Q4 according to their latest regulatory filings, with 42 funds opening new positions, 70 increasing their positions, 76 reducing their positions, and 39 closing their positions.

New
Increased
Maintained
Reduced
Closed

103% more call options, than puts

Call options by funds: $50.5M | Put options by funds: $24.9M

8% more first-time investments, than exits

New positions opened: 42 | Existing positions closed: 39

0% less funds holding

Funds holding: 220219 (-1)

8% less repeat investments, than reductions

Existing positions increased: 70 | Existing positions reduced: 76

11% less capital invested

Capital invested by funds: $5.5B → $4.89B (-$609M)

13% less funds holding in top 10

Funds holding in top 10: 87 (-1)

Holders
219
Holders Change
-1
Holders Change %
-0.45%
% of All Funds
3.52%
Holding in Top 10
7
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-12.5%
% of All Funds
0.11%
New
42
Increased
70
Reduced
76
Closed
39
Calls
$50.5M
Puts
$24.9M
Net Calls
+$25.7M
Net Calls Change
-$88.3M
Name Holding Trade Value Shares
Change
Change in
Stake
Norges Bank
26
Norges Bank
Norway
$17.6M +$2.44M +116,813 +17%
Goldman Sachs
27
Goldman Sachs
New York
$16.8M -$4.84M -231,411 -23%
T. Rowe Price Associates
28
T. Rowe Price Associates
Maryland
$15.6M -$834K -39,891 -5%
CWG
29
C WorldWide Group
Denmark
$15.2M
Charles Schwab
30
Charles Schwab
California
$14.6M +$545K +26,053 +4%
Northern Trust
31
Northern Trust
Illinois
$13M +$75.1K +3,592 +0.6%
D.E. Shaw & Co
32
D.E. Shaw & Co
New York
$12.5M +$2.49M +119,012 +26%
Bank of America
33
Bank of America
North Carolina
$12.3M +$951K +45,477 +9%
PHS
34
PFM Health Sciences
California
$12.2M -$3.3M -157,605 -22%
GCM
35
Glendon Capital Management
California
$10.5M
Bank of New York Mellon
36
Bank of New York Mellon
New York
$9.95M +$334K +15,988 +4%
Royal Bank of Canada
37
Royal Bank of Canada
Ontario, Canada
$9.87M -$948K -45,337 -9%
1832 Asset Management
38
1832 Asset Management
Ontario, Canada
$9.8M -$578K -27,630 -6%
Barclays
39
Barclays
United Kingdom
$9.5M -$1.63M -77,738 -15%
Deutsche Bank
40
Deutsche Bank
Germany
$8.25M -$1.15M -55,077 -13%
DT
41
Diversified Trust
Tennessee
$7.64M +$1.76M +84,000 +31%
Jennison Associates
42
Jennison Associates
New York
$7.3M -$139K -6,632 -2%
N
43
Nuveen
North Carolina
$6.64M -$4.34M -207,493 -40%
PCM
44
Prelude Capital Management
New York
$6.62M +$2.27M +108,754 +55%
CA
45
CapWealth Advisors
Tennessee
$6.46M
GEH
46
General Equity Holdings
New York
$6.15M
Swiss National Bank
47
Swiss National Bank
Switzerland
$5.64M +$107K +5,100 +2%
CP
48
CenterBook Partners
Connecticut
$5.62M +$3.95M +188,622 +260%
SFI
49
Susquehanna Fundamental Investments
Pennsylvania
$5.56M +$5.41M +258,599 New
RPAM
50
Rhenman & Partners Asset Management
Sweden
$5.38M +$5.23M +250,000 New

OSH Hedge Fund Activity: Q4 2022 in Review

219 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in Oak Street Health, Inc. (OSH) for Q4 2022, worth a combined $4.89B — down 11% from $5.5B a quarter earlier.

Buyers outnumbered sellers: 42 funds opened new OSH positions and 39 closed out — a net gain of 3 holders — while 70 added to existing stakes and 76 trimmed.

The largest buyer was Capital World Investors, adding an estimated $86.3M. The largest seller was Capital Research Global Investors, cutting an estimated $30.5M.

  • 219 institutional investors held Oak Street Health, Inc. (OSH) as of Q4 2022, down from 220 in Q3 2022.
  • Funds reported $4.89B of Oak Street Health, Inc. stock for Q4 2022, down 11% quarter-over-quarter.
  • 42 funds opened new Oak Street Health, Inc. positions in Q4 2022 and 39 closed out, a net change of +3 holders.
  • The largest Oak Street Health, Inc. buyer in Q4 2022 was Capital World Investors, an estimated $86.3M added.
  • The largest Oak Street Health, Inc. seller in Q4 2022 was Capital Research Global Investors, an estimated $30.5M sold.

Based on aggregated 13F filings for Q4 2022.